Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA Professor Joseph Jankovic, Parkinson's Disease Center and Movement ...

Professor Andrew Lees of the National Hospital for Neurology and Neurosurgery, Queen Square describes the clinico-pathological studies at the Queen Square Brain Bank that have led to improved ...

Department of Neurosurgery, Istituto Nazionale Neurologico C. Besta, Milan, Italy Dr Giovanni Broggi, Department of Neurosurgery, Istituto Nazionale Neurologico C Besta, Via Celoria 11, 20133 Milan, ...

a Department of Clinical Psychology, St John’s Hospital, Howden Road West, Livingston, West Lothian EH54 6PP, Scotland, UK, b Department of Psychology, Stirling University, Stirling, Scotland, UK Dr ...

a Secure Care Program, Department of Psychiatry, Taunton State Hospital, Taunton, MA, USA, and Harvard Medical School, Boston, MA, USA, b Departments of Neurology ...

Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH8 9YL, UK; laura.mcwhirter{at}ed.ac.uk Performance validity tests (PVTs) are widely used ...

1 Department of Neurosciences and Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal 2 Department of Clinical Neuroscience, Barts and the London School of ...

Anticoagulation substantially reduces the risk of stroke in patients with atrial fibrillation (AF). However, recent studies have shown that up to 22%–36% of patients on anticoagulation will suffer an ...

Correspondence to: Dr E H Reynolds, Institute of Epileptology, Weston Education Centre, King's College Denmark Hill Campus, Cutcombe Road, London SE5 9PJ, UK During three decades of neurological ...

Department of Neurology, University of Florida College of Medicine/Shands Hospital, Movement Disorders Center, McKnight Brain Institute, Gainesville, Florida, USA Objective: To determine how ...

Background Incomplete attack remission is the main cause of disability in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Apheresis therapies such as plasma exchange and ...